Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuvirtide and Rifampin Interaction Study
NCT04006353Phase 4Completed
- Start
- Jul 2019
- Primary completion
- Sep 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of albuvirtide in human immunodeficiency virus type 1 infection (HIV-1). Started Jul 2019; status: completed.
02
Drugs
albuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04006353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006353.